Table 2.
Sociodemographic and medical characteristics of 53,963 patients seeking medical cannabis certification from CB2 Insights clinics in five states
| Characteristic | Massachusetts | Colorado | Maine | Connecticut | Maryland | Total |
|---|---|---|---|---|---|---|
|
n = 27,892 mean (SD) or n (%) |
n = 16,434 mean (SD) or n (%) |
n = 4591 mean (SD) or n (%) |
n = 2643 mean (SD) or n (%) |
n = 2403 mean (SD) or n (%) |
n = 61,379 mean (SD) or % |
|
| Age (years), mean (SD)a,b | 47.0 (15.9) | 43.3 (15.9) | 46.2 (15.6) | 42.2 (14.4) | 45.7 (15.7) | 45.5 (15.8) |
| Gender | ||||||
| Male | 14,615 (52.4%) | 9,969 (60.7%) | 2,720 (59.2%) | 1,506 (57.0%) | 1,019 (42.4%) | 54.8% |
| Female | 10,413 (37.3%) | 6,353 (38.7%) | 1,746 (38.0%) | 1,067 (40.4%) | 714 (29.7%) | 37.8% |
| Non-binary | 12 (0.0%) | 5 (0.0%) | 1 (0.0%) | 6 (0.2%) | 4 (0.2%) | 0.1% |
| Unknown/unspecified | 2,851 (10.2%) | 107 (0.7%) | 124 (2.7%) | 64 (2.4%) | 666 (27.7%) | 7.3% |
| Race | n=11,005 | n=12,266 | n=1,452 | n=1,927 | n=654 | n=32,275 |
| White | 10,304 (93.6%) | 10,372 (84.6%) | 1,396 (96.1%) | 1,615 (83.8%) | 446 (68.2%) | 87.5% |
| Black | 451 (4.1%) | 1,169 (9.5%) | 17 (1.2%) | 268 (13.9%) | 184 (28.1%) | 8.5% |
| Other | 110 (1.0%) | 316 (2.6%) | 20 (1.4%) | 21 (1.1%) | 6 (0.9%) | 1.6% |
| Asian | 94 (0.9%) | 117 (1.0%) | 7 (0.5%) | 13 (0.7%) | 10 (1.5%) | 0.9% |
| American Indian/Alaska Native | 9 (0.1%) | 210 (1.7%) | 10 (0.7%) | 6 (0.3%) | 2 (0.3%) | 0.8% |
| Middle Eastern | 22 (0.2%) | 19 (0.2%) | 0 (0.0%) | 3 (0.2%) | 3 (0.5%) | 0.2% |
| Native Hawaiian/other Pacific Islander | 2 (0.0%) | 47 (0.4%) | 2 (0.1%) | 0 (0.0%) | 2 (0.3%) | 0.2% |
| South East Asian | 13 (0.1%) | 16 (0.1%) | 0 (0.0%) | 1 (0.1%) | 1 (0.2%) | 0.1% |
| Surrogate household income | n=25,182 | n=15,627 | n=4,222 | n=2,595 | n=1,718 | n=56,083 |
| Median | $75,480 | $64,251 | $55,737 | $71,961 | $84,257 | $69,481 |
| (IQR) | ($37,785) | ($32,120) | ($19,633) | ($29,852) | ($37,917) | ($35,807) |
| Smoking statusa,b | ||||||
| Smoker | 3,994 (14.3%) | 4,059 (24.7%) | 1,022 (22.3%) | 638 (24.1%) | 271 (11.3%) | 18.8% |
| Non-Smoker | 23,897 (85.7%) | 12,375 (75.3%) | 3,569 (77.7%) | 2,005 (75.9%) | 2,132 (88.7%) | 81.2% |
| Alcohol consumptiona,b | ||||||
| Yes | 12,459 (44.7%) | 6,323 (38.5%) | 1,905 (41.5%) | 1,081 (40.9%) | 976 (40.6%) | 42.5% |
| No | 15,432 (55.3%) | 10,111 (61.5%) | 2,686 (58.5%) | 1,562 (59.1%) | 1,427 (59.4%) | 57.5% |
| Previous cannabis experiencea,b | ||||||
| Yes | 20,118 (72.1%) | 10,450 (63.6%) | 3,509 (76.4%) | 1,959 (74.1%) | 1,399 (58.2%) | 66.9% |
| No | 7,773 (27.9%) | 5,984 (36.4%) | 1,082 (23.6%) | 684 (25.9%) | 1,004 (41.8%) | 33.1% |
| Use of non-cannabis illicit drugs | ||||||
| Yes | 95 (0.3%) | 89 (0.5%) | 15 (0.3%) | 12 (0.5%) | 5 (0.2%) | 0.4% |
| No | 27,796 (99.7%) | 16,345 (99.5%) | 4,576 (99.7%) | 2,631 (99.5%) | 2,398 (99.8%) | 99.6% |
| History of substance abusea,b | ||||||
| Yes | 1,875 (6.7%) | 380 (2.3%) | 296 (6.4%) | 330 (12.5%) | 81 (3.4%) | 5.6% |
| No | 26.016 (93.3%) | 16,054 (97.7%) | 4,295 (93.6%) | 2,313 (87.5%) | 2,322 (96.6%) | 94.4% |
| Number of medicationsa,b | ||||||
| 0 | 14,272 (51.2%) | 11,233 (68.4%) | 2,625 (57.2%) | 1,252 (47.4%) | 1,216 (50.6%) | 55.8% |
| 1 | 3,780 (13.6%) | 1,601 (9.7%) | 569 (12.4%) | 358 (13.5%) | 427 (17.8%) | 12.8% |
| 2 | 2,263 (8.1%) | 956 (5.8%) | 399 (8.7%) | 210 (8.0%) | 226 (9.4%) | 7.7% |
| 3 | 1,683 (6.0%) | 738 (4.5%) | 244 (5.3%) | 179 (6.8%) | 158 (6.6%) | 5.7% |
| 4 | 1,115 (4.0%) | 515 (3.1%) | 167 (3.6%) | 120 (4.5%) | 124 (5.1%) | 3.9% |
| 5+ | 4,779 (17.1%) | 1,391 (8.5%) | 587 (12.8%) | 524 (19.8%) | 252 (10.5%) | 14.0% |
| Average number of medications | 2.2 (3.5) | 1.2 (2.5) | 1.7 (3.1) | 2.5 (3.7) | 1.7 (2.8) | 2.1 (4.8) |
| Number of non-pharmacologic therapies used | ||||||
| 0 | 10,408 (37.3%) | 7,979 (48.6%) | 1,570 (34.2%) | 997 (37.7%) | 1,065 (44.3%) | 40.6% |
| 1 | 5,558 (19.9%) | 3,537 (21.5%) | 1,121 (24.4%) | 586 (22.2%) | 487 (20.3%) | 20.9% |
| 2 | 4,461 (16.0%) | 2,256 (13.7%) | 789 (17.2%) | 388 (14.7%) | 322 (13.4%) | 15.3% |
| 3 | 3,184 (11.4%) | 1,264 (7.7%) | 503 (11.0%) | 265 (10.0%) | 264 (11.0%) | 10.1% |
| 4 | 1,904 (6.9%) | 674 (4.1%) | 273 (5.9%) | 181 (6.8%) | 148 (6.2%) | 6.0% |
| 5+ | 2,377 (8.5%) | 724 (4.4%) | 335 (7.3%) | 226 (8.6%) | 117 (4.9%) | 7.1% |
| Non-pharmacologic therapies | ||||||
| Exercise | 12,540 (45.0%) | 5,935 (36.1%) | 2,151 (46.9%) | 1,137 (43.0%) | 935 (38.9%) | 42.1% |
| Massage therapy | 6,750 (24.2%) | 2,937 (17.9%) | 972 (21.2%) | 511 (19.3%) | 466 (19.4%) | 21.6% |
| Chiropractor | 5,540 (19.9%) | 2,272 (13.8%) | 1,050 (22.9%) | 362 (13.7%) | 349 (14.5%) | 18.0% |
| Mental health counselling | 6,117 (21.9%) | 1,579 (9.6%) | 864 (18.8%) | 757 (28.6%) | 421 (17.5%) | 18.3% |
| Physiotherapy | 1,342 (4.8%) | 1,270 (7.7%) | 215 (4.7%) | 102 (3.9%) | 100 (4.2%) | 5.5% |
| Mindfulness-based cognitive therapy | 2,760 (9.9%) | 1,111 (6.8%) | 251 (5.5%) | 295 (11.2%) | 175 (7.3%) | 8.4% |
| Aromatherapy | 1,669 (6.0%) | 1,015 (6.2%) | 293 (6.4%) | 211 (8.0%) | 139 (5.8%) | 6.3% |
| Homeopathic medicine | 1,467 (5.3%) | 793 (4.8%) | 278 (6.1%) | 123 (4.7%) | 92 (3.8%) | 5.2% |
| Acupuncture | 3,309 (11.9%) | 769 (4.7%) | 503 (11.0%) | 206 (7.8%) | 243 (10.1%) | 9.2% |
| Cognitive behavioural therapy (CBT) | 1,885 (6.8%) | 478 (2.9%) | 270 (5.9%) | 213 (8.1%) | 115 (4.8%) | 5.7% |
| Naturopathic medicine | 860 (3.1%) | 403 (2.5%) | 149 (3.2%) | 104 (3.9%) | 49 (2.0%) | 2.9% |
| Reiki | 1,380 (4.9%) | 308 (1.9%) | 205 (4.5%) | 113 (4.3%) | 71 (3.0%) | 3.8% |
| Addictions counselling | 602 (2.2%) | 137 (0.8%) | 131 (2.9%) | 115 (4.4%) | 35 (1.5%) | 1.9% |
| Acudetox | 19 (0.1%) | 29 (0.2%) | 7 (0.2%) | 4 (0.2%) | 6 (0.2%) | 0.1% |
| Other | 42 (0.1%) | 11 (0.1%) | 18 (0.4%) | 8 (0.3%) | 8 (0.3%) | 0.4% |
| Number of comorbid conditions | ||||||
| 0 | 2,206 (7.9%) | 6,263 (38.1%) | 294 (6.4%) | 212 (8.0%) | 213 (8.9%) | 17.6% |
| 1 | 5,719 (20.5%) | 5,548 (33.8%) | 940 (20.5%) | 429 (16.2%) | 663 (27.6%) | 26.0% |
| 2 | 4,935 (17.7%) | 2,540 (15.5%) | 991 (21.6%) | 402 (15.2%) | 459 (19.1%) | 16.1% |
| 3 | 4,028 (14.4%) | 1,183 (7.2%) | 700 (15.2%) | 370 (14.0%) | 415 (17.3%) | 11.9% |
| 4 | 3,276 (11.8%) | 548 (3.3%) | 531 (11.6%) | 310 (11.7%) | 253 (10.5%) | 9.0% |
| 5+ | 7,728 (27.7%) | 352 (2.1%) | 1,135 (24.7%) | 920 (34.9%) | 400 (16.6%) | 19.4% |
| Total number of conditions, mean (SD)a,b | 4.3 (2.8) | 2.1 (1.3) | 4.1 (2.6) | 4.8 (3.1) | 3.6 (2.1) | 3.7 (2.6) |
Table 2 summarizes key patient characteristics of patients seeking medical cannabis access at CB2 Insights clinics between November 2018 and March 2020 across five states. The total column includes all 61,379 patients included in the initial study for comparison, including patients from 12 states (Mahabir et al. 2020). Total number of conditions refers to a count of the number of comorbid conditions plus one for the patients’ primary condition. SD = standard deviation
aIndicates that statistical test for significance was completed between the five states; the total numbers were not included in statistical tests. ANOVA was conducted for average age and average number of conditions between states. Chi-squared tests were conducted for differences in proportions between states
bIndicates that statistical test was significant, and the characteristic was significantly different between states